Search Results 201-210 of 257 for ☆【아시아365.COM / 가입코드GK】 땅콩검증 BLACK가입☆

1. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility. Participant ...

2. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.

3. A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

   The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and ...

4. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the pre- ...

5. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

   This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients with ...

6. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

   Cohort 1 will enroll approximately 73 RRMM subjects with ≥ 3 prior anti-myeloma treatment regimens. Cohort 2 will enroll approximately 49 MM subjects with 1 ...

7. Authorized Appointment Services in China - Mayo Clinic

   8 Jianguomenwai Ave. Chao Yang District Beijing China 100022. Phone number: (+86) 010-56732678. Contact email: services@stluciabj.com. Contact person: Xiaoyu ...

8. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate and prednisone (AA-P) compared to AA-P plus ...

9. A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

10. A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...